Regeneron Pharmaceuticals (REGN) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

REGN Regeneron Pharmaceuticals

Watchlist

733.590
+3.290+0.45%

Close Jan 8 16:00 ET

733.590
0.0000.00%

Post 20:01 ET

80.61BMarket Cap18.14P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Obesity Treatments, M&A Activity To Take Center Stage During Upcoming JPM Healthcare Conference
Benzinga14:12 ET
Novo, Eli Lilly to Dominate Global Pharma Sales in 2025: Report
Seeking AlphaJan 9 08:56 ET
S&P 500 Positive for 'First Five Days,' Huang Sees Decades till Quantum | Wall Street Today
Kevin TraversJan 8 16:12 ET
Nation's Top 300 Teen Scientists Selected for Achievements in STEM Innovation and Leadership in Nation's Oldest and Most Prestigious High School Competition
PR NewswireJan 8 12:01 ET
Wednesday Market Falls, Quantum Computing Pulls Back Hard on Treasury Yield Crunch | Live Stock
Kevin TraversJan 8 11:06 ET
The Easy Money Has Been Made in Options. What to Do Now.
BarronsJan 8 01:30 ET

Comments

韭菜变主力

Jan 7 23:51

$Regeneron Pharmaceuticals (REGN.US)$ This is in NDX and could benefit from the weakness of mega-cap tech stocks in the index.

韭菜变主力

Dec 31 16:47

$Regeneron Pharmaceuticals (REGN.US)$Nice. It’s quiet here and just broke the steep down trend.

10xStockPicks

Dec 15, 2024 18:30

A.i Predicts Big Pharma Will Soon Acquire Esperion Therapeutics for $12 to $16 A share, Current Price $2.25

$Esperion Therapeutics (ESPR.US)$ Acquiring Esperion Therapeutics could be a strategic move for a big pharmaceutical company for several compelling reasons. Here are the main factors that suggest an acquisition could be beneficial for a larger player in the pharmaceutical industry:
1. Unique Market Position in Statin Alternatives
– Addressing Statin Intolerance: There are millions of statin...

10xStockPicks

Dec 14, 2024 21:19

This $2.25 Stock Soon To Turn A Profit Is Highly Likely To Be Acquired Above $10

This unique biotech $Esperion Therapeutics (ESPR.US)$ Esperion has the only FDA approved statin alternative drugs NEXLIZET & NEXLETOL for Primary Prevention, Statins are a class of prescription drugs that help lower cholesterol levels. They are the most common treatment for high cholesterol, an estimated 21 Million Americans are Statin intolerant and or maxed out on Statin drugs and need additional lowering. Over 71 ...